Schizophrenia, vitamin D, and brain development.

[1]  J. Coyle,et al.  Glutamatergic mechanisms in schizophrenia. , 2003, Annual review of pharmacology and toxicology.

[2]  R. Yolken,et al.  Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera , 2003, Schizophrenia Research.

[3]  Hongkui Zeng,et al.  Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Susumu Tonegawa,et al.  Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Kirov,et al.  Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[6]  D. Eyles,et al.  Vitamin D receptor expression in the embryonic rat brain , 2003 .

[7]  Michael C O'Donovan,et al.  A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. , 2003, American journal of human genetics.

[8]  R. Buchanan,et al.  Association between Val108/158 met polymorphism of the COMT gene and schizophrenia , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[9]  Leena Peltonen,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.

[10]  Daniel R Weinberger,et al.  Catechol O-Methyltransferase (COMT) mRNA Expression in the Dorsolateral Prefrontal Cortex of Patients with Schizophrenia , 2003, Neuropsychopharmacology.

[11]  D. Eyles,et al.  1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons , 2003, Neuroscience Letters.

[12]  K. Jellinger.  Rett Syndrome – an update , 2003, Journal of Neural Transmission.

[13]  Fan Wang,et al.  Neurotrophins and Netrins Require Calcineurin/NFAT Signaling to Stimulate Outgrowth of Embryonic Axons , 2003, Cell.

[14]  A. Mackay-Sim,et al.  Vitamin d3 and brain development , 2003, Neuroscience.

[15]  A. Renieri,et al.  Rett syndrome: the complex nature of a monogenic disease , 2003, Journal of Molecular Medicine.

[16]  M. Rietschel,et al.  Family‐based and case–control study of catechol‐O‐methyltransferase in schizophrenia among Palestinian Arabs , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[17]  S. Christian,et al.  Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. , 2003, American journal of human genetics.

[18]  M C O'Donovan,et al.  Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia , 2003, Molecular Psychiatry.

[19]  M. Gill,et al.  No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study , 2003, Schizophrenia Research.

[20]  N. Šestan,et al.  Neuregulin 1–erbB2 signaling is required for the establishment of radial glia and their transformation into astrocytes in cerebral cortex , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  B. Kolachana,et al.  Catechol-O-Methyltransferase Genotype and Dopamine Regulation in the Human Brain , 2003, The Journal of Neuroscience.

[22]  Douglas L Falls,et al.  Neuregulins: functions, forms, and signaling strategies. , 2003, Experimental cell research.

[23]  D. Clair,et al.  A family-based association study of T1945C polymorphism in the proline dehydrogenase gene and schizophrenia in the Chinese population , 2003, Neuroscience Letters.

[24]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[25]  Shih-Jen Tsai,et al.  Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females , 2003, Neuroscience Letters.

[26]  S. Akbarian.  The Neurobiology of Rett Syndrome , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[27]  Paul J. Harrison,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Genes for Schizophrenia? Recent Findings and Their Pathophysiological Implications , 2022 .

[28]  E. Cantor-Graae,et al.  Migration as a risk factor for schizophrenia: A Danish population-based cohort study , 2003, British Journal of Psychiatry.

[29]  R. Perez-Fernandez,et al.  1,25-Dihydroxyvitamin D(3) increases striatal GDNF mRNA and protein expression in adult rats. , 2002, Brain research. Molecular brain research.

[30]  A. Guidotti,et al.  An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Beckmann,et al.  A highly significant association between a COMT haplotype and schizophrenia. , 2002, American journal of human genetics.

[32]  M. Butler.  Imprinting disorders: non-Mendelian mechanisms affecting growth. , 2002, Journal of pediatric endocrinology & metabolism : JPEM.

[33]  U. Mrowietz,et al.  Vitamin D3 and analogues modulate the expression of CSF-1 and its receptor in human dendritic cells , 2002 .

[34]  P. Sham,et al.  Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[36]  B. Yu,et al.  Catechol O-methyltransferase genetic polymorphism in panic disorder. , 2002, The American journal of psychiatry.

[37]  J. Lieberman,et al.  Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia , 2002, Biological Psychiatry.

[38]  D. Campion,et al.  PRODH mutations and hyperprolinemia in a subset of schizophrenic patients. , 2002, Human molecular genetics.

[39]  D. Kang,et al.  Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia , 2002, European Neuropsychopharmacology.

[40]  I. Pogribny,et al.  DNA methylation in Folbp1 knockout mice supplemented with folic acid during gestation. , 2002, The Journal of nutrition.

[41]  G. Wolff,et al.  Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. , 2002, The Journal of nutrition.

[42]  R. Weksberg,et al.  Schizophrenia and genetics: New insights , 2002, Current psychiatry reports.

[43]  B. Kirkpatrick,et al.  Glucocorticoid Hormones and Early Brain Development in Schizophrenia , 2002, Neuropsychopharmacology.

[44]  R. Straub,et al.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. , 2002, American journal of human genetics.

[45]  Ying Chen,et al.  On the epigenetic regulation of the human reelin promoter , 2002, Nucleic Acids Res..

[46]  B. Devlin,et al.  Association and linkage analyses of RGS4 polymorphisms in schizophrenia. , 2002, Human molecular genetics.

[47]  J. Wong,et al.  Nuclear receptor-dependent transcription with chromatin. Is it all about enzymes? , 2002, European journal of biochemistry.

[48]  François Berger,et al.  New clues about vitamin D functions in the nervous system , 2002, Trends in Endocrinology & Metabolism.

[49]  J. Pierri,et al.  Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia , 2002, The Journal of Neuroscience.

[50]  J. Coyle,et al.  Ionotropic glutamate receptors as therapeutic targets in schizophrenia. , 2002, Current drug targets. CNS and neurological disorders.

[51]  M. Owen,et al.  Genome scans and microarrays: converging on genes for schizophrenia? , 2002, Genome Biology.

[52]  Ellen M Wijsman,et al.  Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  T. Ingi,et al.  Expression of RGS2, RGS4 and RGS7 in the developing postnatal brain , 2002, The European journal of neuroscience.

[54]  M. Weinstock.  Alterations induced by gestational stress in brain morphology and behaviour of the offspring , 2001, Progress in Neurobiology.

[55]  Hongkui Zeng,et al.  Forebrain-Specific Calcineurin Knockout Selectively Impairs Bidirectional Synaptic Plasticity and Working/Episodic-like Memory , 2001, Cell.

[56]  P. Mortensen,et al.  Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. , 2001, Archives of general psychiatry.

[57]  R. Yolken,et al.  Maternal infections and subsequent psychosis among offspring. , 2001, Archives of general psychiatry.

[58]  S. Fatemi,et al.  Altered levels of Reelin and its isoforms in schizophrenia and mood disorders , 2001, Neuroreport.

[59]  J. McGrath,et al.  Vitamin D: the neglected neurosteroid? , 2001, Trends in Neurosciences.

[60]  S. Grover,et al.  Vitamin D deficiency in veiled or dark‐skinned pregnant women , 2001, The Medical journal of Australia.

[61]  Pat Levitt,et al.  Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse , 2001, Trends in Neurosciences.

[62]  M. Webster,et al.  Application of cDNA microarrays to examine gene expression differences in schizophrenia , 2001, Brain Research Bulletin.

[63]  M. Webster,et al.  Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium , 2001, Brain Research Bulletin.

[64]  P. Mortensen,et al.  Family history, place and season of birth as risk factors for schizophrenia in Denmark: A replication and reanalysis , 2001, British Journal of Psychiatry.

[65]  D. Blake,et al.  Dysbindin, a Novel Coiled-coil-containing Protein That Interacts with the Dystrobrevins in Muscle and Brain* , 2001, The Journal of Biological Chemistry.

[66]  B. Hoffer,et al.  Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats , 2001, Brain Research.

[67]  G. Csaba,et al.  The effect of a single neonatal treatment (hormonal imprinting) with the antihormones, tamoxifen and mifepristone on the sexual behavior of adult rats. , 2001, Pharmacological research.

[68]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[69]  V. Rakyan,et al.  The marks, mechanisms and memory of epigenetic states in mammals. , 2001, The Biochemical journal.

[70]  E. Cantor-Graae,et al.  Increased rates of psychosis among immigrants to Sweden: is migration a risk factor for psychosis ? , 2001, Psychological Medicine.

[71]  D. Lewis,et al.  Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.

[72]  J. P. Herman,et al.  Evidence of functional vitamin D receptors in rat hippocampus , 2001, Neuroscience.

[73]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[74]  H. Hoek,et al.  Incidence of psychotic disorders in immigrant groups to The Netherlands. , 2001, The British journal of psychiatry : the journal of mental science.

[75]  J. Bartko,et al.  Schizophrenia and season of birth in a tropical region: relationship to rainfall , 2001, Schizophrenia Research.

[76]  R. Vieth,et al.  Difficulties with vitamin D nutrition research: objective targets of adequacy, and assays for 25-hydroxyvitamin D , 2001, European Journal of Clinical Nutrition.

[77]  J. McGrath,et al.  Does 'imprinting' with low prenatal vitamin D contribute to the risk of various adult disorders? , 2001, Medical hypotheses.

[78]  Birgit Funke,et al.  TBX1 Is Responsible for Cardiovascular Defects in Velo-Cardio-Facial/DiGeorge Syndrome , 2001, Cell.

[79]  A. Parisi,et al.  Vitamin D insufficiency in south‐east Queensland , 2001, The Medical journal of Australia.

[80]  G. Anderson.  Thyroid Hormones and the Brain , 2001, Frontiers in Neuroendocrinology.

[81]  Philip W. Landfield,et al.  Vitamin D Hormone Confers Neuroprotection in Parallel with Downregulation of L-Type Calcium Channel Expression in Hippocampal Neurons , 2001, The Journal of Neuroscience.

[82]  Yogesh K. Dwivedi,et al.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.

[83]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[84]  W. Miller,et al.  Vitamin D 1α-Hydroxylase , 2000, Trends in Endocrinology & Metabolism.

[85]  P. Brachet,et al.  Rat oligodendrocytes express the vitamin D3 receptor and respond to 1,25‐dihydroxyvitamin D3 , 2000, Glia.

[86]  Anthony J. Muslin,et al.  RGS proteins inhibit Xwnt-8 signaling in Xenopus embryonic development. , 2000, Development.

[87]  L. DeLisi,et al.  Investigation of a candidate gene for schizophrenia on Xq13 previously associated with mental retardation and hypothyroidism. , 2000, American journal of medical genetics.

[88]  N. Swerdlow,et al.  Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. , 2000, Behavioural pharmacology.

[89]  W. Honer,et al.  Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. , 2000, Science.

[90]  T. Hayashi,et al.  Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats , 2000, Neuropharmacology.

[91]  A. Sampson,et al.  Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. , 2000, Archives of general psychiatry.

[92]  J. Mcgrath.  Hypothesis: Is low prenatal vitamin D a risk-modifying factor for schizophrenia? , 1999, Schizophrenia Research.

[93]  A. Asai,et al.  High Level Calcineurin Activity Predisposes Neuronal Cells to Apoptosis* , 1999, The Journal of Biological Chemistry.

[94]  M. Jäättelä,et al.  Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. , 1999, Cancer research.

[95]  M. Álvarez-Dolado,et al.  Thyroid Hormone Regulates reelin and dab1Expression During Brain Development , 1999, The Journal of Neuroscience.

[96]  A. LaMantia.  Forebrain induction, retinoic acid, and vulnerability to schizophrenia: insights from molecular and genetic analysis in developing mice , 1999, Biological Psychiatry.

[97]  M. Karayiorgou,et al.  The gene encoding proline dehydrogenase modulates sensorimotor gating in mice , 1999, Nature Genetics.

[98]  T. Veenstra,et al.  Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord , 1999, Journal of Chemical Neuroanatomy.

[99]  W. Lee,et al.  Differential regulation of glial cell line–derived neurotrophic factor (GDNF) expression in human neuroblastoma and glioblastoma cell lines , 1999, Journal of neuroscience research.

[100]  Yogesh K. Dwivedi,et al.  A decrease of reelin expression as a putative vulnerability factor in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[101]  S. Brimijoin,et al.  1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo , 1998, Brain Research.

[102]  P. Landfield,et al.  Long-term treatment with Calcitriol (1,25(OH)2 vit D3) retards a biomarker of hippocampal aging in rats , 1998, Neurobiology of Aging.

[103]  L. Freedman,et al.  Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. , 1998, Molecular endocrinology.

[104]  T. Jessell,et al.  Motor Neuron–Derived Retinoid Signaling Specifies the Subtype Identity of Spinal Motor Neurons , 1998, Cell.

[105]  R. Kodell,et al.  Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[106]  Looker Ac,et al.  Hypovitaminosis D in medical inpatients. , 1998 .

[107]  R. Murray,et al.  Urbanization and psychosis: a study of 1942–1978 birth cohorts in The Netherlands , 1998, Psychological Medicine.

[108]  A. Goodman.  Three independent lines of evidence suggest retinoids as causal to schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[109]  A. LaMantia,et al.  Retinoid signaling distinguishes a subpopulation of olfactory receptor neurons in the developing and adult mouse , 1998, The Journal of comparative neurology.

[110]  P Chambon,et al.  Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. , 1998, Science.

[111]  S. Lawrie,et al.  Brain abnormality in schizophrenia , 1998, British Journal of Psychiatry.

[112]  P. Chambon,et al.  Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[113]  R. Yolken,et al.  Seasonality of births in schizophrenia and bipolar disorder: a review of the literature , 1997, Schizophrenia Research.

[114]  D. Levinson,et al.  The Molecular Genetics of Schizophrenia: An Update , 1997, The Australian and New Zealand journal of psychiatry.

[115]  G. Jirikowski,et al.  1.25-Dihydroxyvitamin D3 receptor is partly colocalized with oxytocin immunoreactivity in neurons of the male rat hypothalamus. , 1997, Cellular and molecular biology.

[116]  J. Ott,et al.  Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[117]  T. Arinami,et al.  A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. , 1997, Human molecular genetics.

[118]  G. Csaba,et al.  Effect of perinatal vitamin A or retinoic acid treatment (hormonal imprinting) on the sexual behavior of adult rats , 1997, Human & experimental toxicology.

[119]  A. K. Jarvis,et al.  1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. , 1997, The American journal of physiology.

[120]  S. Brimijoin,et al.  Effects of 1,25-dihydroxyvitamin D3 on growth of mouse neuroblastoma cells. , 1997, Brain research. Developmental brain research.

[121]  P. Brachet,et al.  Differential expression of M‐CSF, LIF, and TNF‐α genes in normal and malignant rat glial cells: Regulation by lipopolysaccharide and vitamin D , 1996, Journal of neuroscience research.

[122]  P. Brachet,et al.  1,25‐Dihydroxyvitamin D3, an inducer of glial cell line‐derived neurotrophic factor , 1996, Neuroreport.

[123]  A. Mackay-Sim,et al.  Olfactory neuronal cell lines generated by retroviral insertion of the n‐myc oncogene display different developmental phenotypes , 1996, Journal of neuroscience research.

[124]  G. Csaba,et al.  Changes in sexual behavior of adult male and female rats neonatally treated with vitamin D3 , 1996, Human & experimental toxicology.

[125]  A. Goodman.  Congenital anomalies in relatives of schizophrenic probands may indicate a retinoid pathology , 1996, Schizophrenia Research.

[126]  E. Arenas,et al.  Neurotrophins promote the survival and development of neurons in the cerebellum of hypothyroid rats in vivo , 1996, The Journal of cell biology.

[127]  G. Csaba,et al.  Hormonal imprinting: Neonatal treatment of rats with the peroxysome proliferator clofibrate irreversibly affects sexual behaviour , 1995, Physiology & Behavior.

[128]  J. Welham,et al.  Month of Birth, Hemisphere of Birth and Schizophrenia , 1995, British Journal of Psychiatry.

[129]  N. Swerdlow,et al.  Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine , 1995, Psychopharmacology.

[130]  J. Lefebvre,et al.  Effects of vitamin D3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT 29 cells: possible implication of intracellular calcium. , 1995, Cancer letters.

[131]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[132]  C. Mathieu,et al.  Immunomodulatory effects of 1,25‐dihydroxyvitamin D3 , 1995, Current opinion in nephrology and hypertension.

[133]  M. Holick,et al.  Environmental factors that influence the cutaneous production of vitamin D 13 , 1995 .

[134]  R. Yolken,et al.  Viruses, schizophrenia, and bipolar disorder , 1995, Clinical microbiology reviews.

[135]  P. Brachet,et al.  1,25‐Dihydroxyvitamin D3 regulates NT‐3, NT‐4 but not BDNF mRNA in astrocytes , 1994, Neuroreport.

[136]  M. Álvarez-Dolado,et al.  Expression of neurotrophins and the trk family of neurotrophin receptors in normal and hypothyroid rat brain. , 1994, Brain research. Molecular brain research.

[137]  C. Bell.  DSM-IV: Diagnostic and Statistical Manual of Mental Disorders , 1994 .

[138]  P. Brachet,et al.  1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. , 1994, Brain research. Molecular brain research.

[139]  C. Carlberg,et al.  Thyroid hormone and retinoic acid receptors form heterodimers with retinoid X receptors on direct repeats, palindromes, and inverted palindromes. , 1994, DNA and cell biology.

[140]  M. E. Lewis,et al.  Pharmacological Induction of Nerve Growth Factor mRNA in Adult Rat Brain , 1993, Experimental Neurology.

[141]  H. Bidmon,et al.  Vitamin d nuclear binding to neurons of the septal, substriatal and amygdaloid area in the siberian hamster (Phodopus sungorus) brain , 1992, Neuroscience.

[142]  M. Somerville,et al.  Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. , 1992, Brain research. Molecular brain research.

[143]  L. DeLisi,et al.  Familial thyroid disease and delayed language development in first admission patients with schizophrenia , 1991, Psychiatry Research.

[144]  R. Houlgatte,et al.  1,25‐Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis , 1991, Journal of neuroscience research.

[145]  M. Holick,et al.  Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. , 1988, The Journal of clinical endocrinology and metabolism.

[146]  W. Stumpf,et al.  1,25(OH)2 vitamin D3 sites of action in the brain , 1987, Histochemistry.

[147]  D. Weinberger.  Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.

[148]  F. Glorieux,et al.  In vitro metabolism of 25-hydroxycholecalciferol by isolated cells from human decidua. , 1985, The Journal of clinical endocrinology and metabolism.

[149]  M. Hughes,et al.  Chronic vitamin D deficiency in the weanling rat alters catecholamine metabolism in the cortex , 1982, Brain Research.

[150]  H. DeLuca,et al.  Brain target sites for 1,25-dihydroxyvitamin D3. , 1982, Science.

[151]  W. Maclennan,et al.  The effects of season and stage of pregnancy on plasma 25-hydroxy-vitamin D concentrations in pregnant women. , 1980, Postgraduate medical journal.

[152]  Margot Albus,et al.  Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. , 2003, American journal of human genetics.

[153]  A. Kakita,et al.  Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development , 2003, Molecular Psychiatry.

[154]  A. Paterson,et al.  Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? , 2003, Schizophrenia bulletin.

[155]  D. Armstrong.  Neuropathology of Rett syndrome. , 2002, Mental retardation and developmental disabilities research reviews.

[156]  C.-H. Chen,et al.  Family-based association studies of COMT gene polymorphisms and schizophrenia in the Chinese population , 2002, Molecular Psychiatry.

[157]  K. Prufer,et al.  Vitamin D receptor and retinoid X receptor interactions in motion. , 2002, Vitamins and hormones.

[158]  E. Hoffman,et al.  Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. , 2002, Mental retardation and developmental disabilities research reviews.

[159]  R. Straub,et al.  Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes , 2002, Molecular Psychiatry.

[160]  S. Fatemi,et al.  Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression , 2000, Molecular Psychiatry.

[161]  M. Kaghad,et al.  Differentially expressed genes in C6.9 glioma cells during vitamin D-induced cell death program , 1998, Cell Death and Differentiation.

[162]  T. Nikaido,et al.  Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. , 1997, British Journal of Cancer.

[163]  G. Csaba,et al.  Effect of neonatal triiodothyronine (T3) treatment (hormonal imprinting) on the sexual behavior of adult rats. , 1997, Acta physiologica Hungarica.

[164]  R. Wüthrich,et al.  1,25-dihydroxyvitamin D3 and the synthetic vitamin D analogue, KH 1060, modulate the growth of mouse proximal tubular cells. , 1996, Kidney & blood pressure research.

[165]  E. Levy,et al.  Effects of calcitriol on proliferation and differentiation of human fetal jejunum. , 1995, Biology of the neonate.

[166]  G. Harrison.  Searching for the causes of schizophrenia: the role of migrant studies. , 1990, Schizophrenia bulletin.